- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07821203
Subincisional Pockets for Sealing Clear Corneal Incisions in Cataract Surgery (SIPSIP)
September 10, 2026 updated by: Philippine Eye Research Institute
Sub-Incisional Pockets for Sealing Phacoemulsification Incisions: A Retrospective Cohort Study
The main goal of the sub-incisional pocket (SIP) is to provide a wound seal option during corneal surgery.
This retrospective cohort study aims to report the efficacy and safety of SIP among eyes undergoing routine cornea surgery as well as to determine factors that could be correlated with wound seal.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
35
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Makati City, Philippines
- Peregrine Eye and Laser Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Patients that have undergone phacoemulsification with the sub-incisional pocket (SIP) from the Peregrine Eye and Laser Institute within the set study period of January 1, 2025 to February 28, 2026.
Description
Inclusion Criteria:
- Adult (≥18 years) participants
- Patients undergoing primary phacoemulsification with clear corneal incision and in-the-bag intraocular acrylic lens
- Uncomplicated cataract surgeries utilizing a 2.2 mm temporal clear corneal incision with sub-incisional stromal pocket.
Exclusion Criteria:
- Medical records from patients with intraoperative complications requiring incisions or suturing
- Prior surgery in the operative eye
- Prior corneal disease or ocular surface disease
- With an inadequate follow-up within 7 days after surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wound seal of participants assessed with the CCI-SIP 4-point ordinal scale by pressure with cotton tip pledget at post-operative day 1.
Time Frame: 6 Weeks
|
Clear corneal incision-Subincisional pocket (CCI-SIP) wound seals were graded on a 4-point ordinal scale: Grade 4, Fully formed AC after removal of all instrumentation with no hydration maneuvers; Grade 3, Flat AC after instrumentation removal, AC reformed after hydrating the side-port incisions only; Grade 2, Flat AC reformed after hydrating both side ports and SIP; and Grade 1, flat AC reformed after hydrating the side ports, SIP and CCI lateral walls.
A higher wound grade denotes better wound sealability.
|
6 Weeks
|
|
Change from 3 months pre-operation in astigmatism as measured by keratometry (diopter) at 6 weeks post-operation.
Time Frame: 6 weeks
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2025
Primary Completion (Actual)
February 28, 2026
Study Completion (Actual)
February 28, 2026
Study Registration Dates
First Submitted
August 24, 2026
First Submitted That Met QC Criteria
September 10, 2026
First Posted (Actual)
September 15, 2026
Study Record Updates
Last Update Posted (Actual)
September 15, 2026
Last Update Submitted That Met QC Criteria
September 10, 2026
Last Verified
September 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RGAO-2026-0520
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.